The PR is dated December 15th, 2008. I don't think anyone is exactly clear on when the appeal was officially submitted. Genta was to meet, formally, with FDA leadership to understand the issues associated with the NDA (reason(s) for non-approval) and address those issues prior to submitting the appeal.
I think the appeal was probably submited late January, early February.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.